Twist Liabilities And Stockholders Equity from 2010 to 2025
| TWST Stock | USD 32.13 0.09 0.28% |
Liabilities And Stockholders Equity | First Reported 2017-09-30 | Previous Quarter 643.6 M | Current Value 641.9 M | Quarterly Volatility 298.6 M |
Check Twist Bioscience financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Twist Bioscience's main balance sheet or income statement drivers, such as Tax Provision of 755 K, Net Interest Income of 11.9 M or Interest Income of 11.9 M, as well as many indicators such as Price To Sales Ratio of 4.25, Dividend Yield of 0.0 or PTB Ratio of 2.26. Twist financial statements analysis is a perfect complement when working with Twist Bioscience Valuation or Volatility modules.
Twist | Liabilities And Stockholders Equity | Build AI portfolio with Twist Stock |
Thematic Opportunities
Explore Investment Opportunities
Additional Tools for Twist Stock Analysis
When running Twist Bioscience's price analysis, check to measure Twist Bioscience's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Twist Bioscience is operating at the current time. Most of Twist Bioscience's value examination focuses on studying past and present price action to predict the probability of Twist Bioscience's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Twist Bioscience's price. Additionally, you may evaluate how the addition of Twist Bioscience to your portfolios can decrease your overall portfolio volatility.